Stefano Fiorucci

发表

Farnesoid X receptor modulators (2011 – 2014): a patent review

V. Sepe, E. Distrutti, A. Zampella, 2015, Expert opinion on therapeutic patents.

The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines

Elisabetta Marino, Stefano Fiorucci, Luigina Graziosi, 2018 .

Endothelial nitric oxide synthase: the Cinderella of inflammation?

Giuseppe Cirino, W. Sessa, S. Fiorucci, 2003, Trends in pharmacological sciences.

Structure-based drug design targeting the cell membrane receptor GPBAR1: exploiting the bile acid scaffold towards selective agonism

Ettore Novellino, Vittorio Limongelli, Francesco Saverio Di Leva, 2015, Scientific Reports.

Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor.

Giuseppe Bifulco, G. Bifulco, V. Sepe, 2011, Journal of medicinal chemistry.

Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.

Marco Migliorati, E. Distrutti, S. Fiorucci, 2011, Biochimica et biophysica acta.

Farnesoid X receptor: from structure to potential clinical applications.

Gabriele Costantino, Roberto Pellicciari, S. Fiorucci, 2005, Journal of medicinal chemistry.

Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.

S. Fiorucci, G. Palladino, A. Mencarelli, 2009, Trends in pharmacological sciences.

FENSAP-ICE Applications to Unmanned Aerial Vehicles (UAV)

Wagdi G. Habashi, Pascal Benquet, W. Habashi, 2004 .

Farnesoid X receptor: from medicinal chemistry to clinical applications.

A. Zampella, S. Fiorucci, A. Mencarelli, 2012, Future medicinal chemistry.